Termination of proposed sale and leaseback transaction
Key points
- Little Green Pharma Ltd (ASX:LGP) announced termination of proposed sale and leaseback of production facility
- Parties were unable to reach commercial agreement on certain conditions precedent
- Termination will not impact LGP's business or operations
Full summary
Little Green Pharma Ltd (ASX:LGP) refers to its previous announcement dated 19 February 2026 where it had signed a Contract to sell and lease back its production facility in South-West Western Australia, subject to various conditions precedent. The Company has now confirmed that the Parties were unable to reach commercial agreement in relation to certain matters the subject of conditions precedent in the Contract, meaning the Contract has now terminated in accordance with its terms. This means the proposed sale and leaseback will not proceed and LGP will continue to own the production facility. Termination of the proposed sale and leaseback is not expected to impact LGP's business or operations.
Summary generated by a large language model. Please interpret with care.